Showing 1 – 2 of 2
Relevance | Newest | Oldest |
  • JAMA Cardiology Original Investigation
    April 17, 2024

    Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial

    Yi听Li,听MD; Jing听Li,听MD; Bin听Wang,听MD; Quanmin听Jing,听MD; Yujie听Zeng,听MD; Aijie听Hou,听MD; Zhifang听Wang,听MD; Aijun听Liu,听MD; Jinliang听Zhang,听MD; Yaojun听Zhang,听MD; Ping听Zhang,听MD; Daming听Jiang,听MD; Bin听Liu,听MD; Jiamao听Fan,听MD; Jun听Zhang,听MD; Li听Li,听MD; Guohai听Su,听MD; Ming听Yang,听MD; Weihong听Jiang,听MD; Peng听Qu,听MD; Hesong听Zeng,听MD, PhD; Lu听Li,听MD; Miaohan听Qiu,听MD; Leisheng听Ru,听MD; Shaoliang听Chen,听MD; Yujie听Zhou,听MD; Shubin听Qiao,听MD; Gregg W.听Stone,听MD; Dominick J.听Angiolillo,听MD, PhD; Yaling听Han,听MD; OPT-BIRISK Investigators
    Abstract Full Text
    online first
    JAMA Cardiol. 2024; 10.1001/jamacardio.2024.0534

    This randomized clinical trial evaluates clopidogrel monotherapy vs dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions who are at high bleeding and ischemic risk.

  • 榴莲视频 Network Open Original Investigation Oncology
    October 5, 2018

    Association of Sustained Response Duration With Survival After Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma

    Yaojun听Zhang,听MD; Mengping听Zhang,听PhD; Minshan听Chen,听MD; Jie听Mei,听MD; Li听Xu,听MD; Rongping听Guo,听MD; Xiaojun听Lin,听MD; Jiaping听Li,听PhD; Zhenwei听Peng,听MD, PhD
    Abstract Full Text
    open access
    榴莲视频 Netw Open. 2018; 1(6):e183213. 10.1001/jamanetworkopen.2018.3213

    This cohort study of patients in China investigates whether sustained response duration of 6 months or more following treatment with conventional transarterial chemoembolization (cTACE) is a reliable surrogate end point for overall survival in patients with intermediate hepatocellular carcinoma (HCC).